risk of medullary thyroid cancer with glp 1 GLP-1RA and cancer: New study suggests detection bias, not causation glp 1 agonist medullary thyroid

Among participants, AHI decreased by an average of 25.3 events per hour in trial 1 (a 50.7% reduction) and 29.3 events per hour in trial 2 (a 58.7% reduction)

Instead, we have shown that in vivo ablation of Gclc in B cells caused a block in B cell differentiation, which results in the absence of MZP

Nat Metab (2024)]

Medical Monitoring Regular assessment of bone health is essential for those on GLP-1 medications: Baseline DEXA scan : Consider getting a bone density test before starting GLP-1 medication Follow-up testing : Repeat every 1-2 years while on medication Blood tests : Check vitamin D, calcium, and bone turnover markers annually Height measurement : Loss of height can be an early warning sign of vertebral fractures Conclusion GLP-1 medications offer powerful benefits for weight management and diabetes control